Goodwin + KPMG 3rd Annual Symposium @ JP Morgan Healthcare Conference

We kicked off last year’s symposium with three industry-focused bursts, starting with the state of the European biotech market and a panel discussing the current trends and themes within the European life sciences sector. The second burst on healthcare started with a look at the hot topics in healthcare regulatory for 2022, followed by a panel on the digital health industry transformation, a fireside chat on innovation in the expanding women’s health and wellness ecosystem, and a panel on privacy trends and technologies that are reshaping healthcare. We closed the first day with a keynote fireside chat with industry luminary Tony Coles, CEO and Chairperson of Cerevel Therapeutics.

Day two of last year’s symposium involved an overview of the capital markets landscape from 2021 leading into 2022. This was followed by a panel discussing the key steps for deciding which type of offering to pursue and how to chart your own course in this ever-changing market, as well as a fireside chat with two CFOs of companies that had recently gone public (eFFECTOR and Caribou Biosciences). The second and final burst of the day started with a fireside chat on the antitrust expansion in life sciences collaborations. We concluded the symposium with a fireside chat with Bonnie Anderson, Co-Founder and Executive Chairwoman of Veracyte, who showcased the keys to innovative deal-making for 2022.